You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 22, 2025

Details for Patent: 4,999,375


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,999,375
Title: Psoralen reagent compositions for extracorporeal treatment of blood
Abstract:Psoralen compositions for extracorporeal administration to blood prior to reinfusion into a subject comprising a sterile aqueous solution of about 0.005 to about 1 mg/ml of a psoralen ethyl alcohol, propylene glycol and water and having a pH from about 2.0 to about 6.0 are disclosed. These compositions are useful for the therapy of a subject being treated by ultraviolet-A photophoresis.
Inventor(s): Bachynsky; Maria O. (Nutley, NJ), Infeld; Martin H. (Upper Montclair, NJ), Margolis; Richard J. (Wayne, NJ), Perla; Dennis A. (Wayne, NJ)
Assignee: Hoffmann-La Roche Inc. (Nutley, NJ)
Application Number:07/336,179
Patent Claim Types:
see list of patent claims
Composition; Formulation; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 4,999,375

To delve into the specifics of United States Patent 4,999,375, it is essential to understand the broader context of patent law, the process of patent application and examination, and the criteria for patent eligibility.

Patent Law Basics

Patents in the United States are governed by the Patent Act (35 U.S. Code) and administered by the United States Patent and Trademark Office (USPTO)[1][2].

Types of Patents

There are several types of patents, including utility patents, design patents, and plant patents. Utility patents, the most common type, protect functional inventions and have a duration of 20 years from the date of filing[1].

Patent Application and Examination Process

To obtain a patent, an applicant must submit a patent application to the USPTO. The application is then reviewed by a patent examiner to determine if the invention is patentable. This process involves several key steps:

Patentability Search

A patentability search is conducted to ensure the invention is novel and non-obvious. This search helps avoid wasteful patent applications by identifying prior art that may render the invention unpatentable[1].

Section 101 Rejections

During the examination process, the patent application must pass the test of Section 101 of the Patent Act, which defines patent-eligible subject matter. This includes ensuring the invention falls within one of the four statutory categories: processes, machines, manufactures, or compositions of matter[5].

Patent Scope and Claims

The scope of a patent is defined by its claims, which are the legal descriptions of the invention for which protection is sought.

Independent Claim Length and Count

Research has shown that the scope of a patent can be measured using metrics such as independent claim length and independent claim count. These metrics have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Narrow vs. Broad Claims

Narrower claims are often associated with a higher probability of grant and a shorter examination process compared to broader claims. This is because narrower claims are more specific and less likely to be rejected for lack of novelty or non-obviousness[3].

Analyzing Patent 4,999,375

Background and Invention

To analyze the scope and claims of Patent 4,999,375, one must first understand the background and the specific invention described in the patent. This involves reviewing the patent's abstract, detailed description, and drawings.

Claims Analysis

The claims section of the patent is crucial as it defines the legal boundaries of the invention. Here, you would analyze each claim to determine what is protected and what is not. This includes identifying independent claims, which are the broadest claims in the patent, and dependent claims, which are narrower and build upon the independent claims.

Section 101 Eligibility

Ensure that the claims of Patent 4,999,375 comply with Section 101 of the Patent Act. This involves checking if the invention falls within the statutory categories and does not fall under the judicially developed exceptions such as abstract ideas, natural phenomena, or laws of nature[5].

Impact of Judicial Decisions

Alice/Mayo Framework

Recent judicial decisions, such as those in the Alice and Mayo cases, have significantly impacted the landscape of patent-eligible subject matter. These decisions have narrowed the scope of what can be patented, particularly in areas like business methods and certain biotechnology inventions. The USPTO's 2019 Guidance aimed to clarify how to apply these frameworks, especially for computer-related inventions[5].

Global and Public Search Tools

Global Dossier and Public Search Facility

Tools like the Global Dossier and the Public Search Facility provided by the USPTO can be invaluable in analyzing the patent landscape. These tools allow users to access file histories of related applications, see the patent family for a specific application, and identify office actions[4].

Key Takeaways

  • Patent Scope: Defined by the claims, which must be specific and novel.
  • Section 101: Ensures the invention falls within statutory categories and avoids judicially developed exceptions.
  • Claims Analysis: Independent and dependent claims define the legal boundaries of the invention.
  • Judicial Impact: Decisions like Alice and Mayo have narrowed patent-eligible subject matter.
  • Search Tools: Global Dossier and Public Search Facility aid in understanding the patent landscape.

FAQs

What is the purpose of a patentability search?

A patentability search is conducted to ensure the invention is novel and non-obvious, avoiding wasteful patent applications by identifying prior art.

How do independent claim length and count affect patent scope?

Narrower claims, as measured by independent claim length and count, are associated with a higher probability of grant and a shorter examination process.

What are the four statutory categories under Section 101 of the Patent Act?

The four categories are processes, machines, manufactures, and compositions of matter.

How have recent judicial decisions impacted patent-eligible subject matter?

Decisions like Alice and Mayo have narrowed the scope of what can be patented, particularly in areas like business methods and certain biotechnology inventions.

What is the role of the USPTO's 2019 Guidance in patent examination?

The 2019 Guidance clarifies how to apply the Alice/Mayo framework, especially for computer-related inventions, and has led to an increase in the allowance rate for patent applications containing AI.

Cited Sources

  1. BitLaw: Summary and Detailed Explanations of Patent Law.
  2. USA.gov: U.S. Patent and Trademark Office (USPTO).
  3. SSRN: Patent Claims and Patent Scope.
  4. USPTO: Search for patents.
  5. CRS Reports: Patent-Eligible Subject Matter Reform: An Overview.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 4,999,375

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 4,999,375

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Austria 87205 ⤷  Try for Free
Denmark 0392429 ⤷  Try for Free
European Patent Office 0392429 ⤷  Try for Free
Germany 59001061 ⤷  Try for Free
Japan H02290814 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.